5:16 PM ET
8-K
Loan & Debt
Rocket Pharmaceuticals $150M Debt Financing with Hercules Capital, Inc.
Rocket Pharmaceuticals entered into a senior secured term loan agreement with Hercules Capital for up to $150.0 million across five tranches. The company received an initial $35.0 million at closing, with subsequent tranches available upon clinical milestones and lender approval to support its Phase 2 study of RP-A501 for Danon disease.
- Value
- $150M
- Counterparty
- Hercules Capital, Inc.
- Term
- Through Oct 2030